CHU de Toulouse
Toulouse, 31000, France
NCT Number: NCT03330158
The purpose of this biomedical research is to evaluate the feasibility of the treatment with the new spinal distraction device ASTS in patients aged 4 to 10 years with severe early onset scoliosis.
The hypothesis of this project is that the new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
The ASTS (for Active Scoliosis Treatment System) growing rod is a new fully implantable motorized spinal distraction device which can ensure a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
This study is active but is not currently recruiting participants.
Notify Me4 year–10 year
All sexes
Interventional
Not applicable
Toulouse, 31000, France
Despite a better understanding and technical progress, the evolutionary early scoliosis remains a therapeutic challenge. The definition includes idiopathic scoliosis beginning before the age of 3 years, congenital scoliosis, neuromuscular and syndromic. Spinal deformity is often progressive and may compromise cardiorespiratory function.
The goal of treatment is to prevent further avoiding spinal fusion in a subject in growth. Surgery is indicated in case of failure or cons-indication of conservative treatment (corset or plaster). The principle is to position the posterior rods subcutaneous or in muscle attached to two ends of the deformation.
Intraoperative distraction allows correction of the deformity. A new distraction is performed every 6 months until skeletal maturity.
Considerable complication rates are reported (58%), mainly implant infections and disassembly, because of the need for multiple reoperations. Motorized implants can potentially avoid repeated interventions limiting complications.
Thus, the central hypothesis of this project is a new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation of a motorized spinal distraction rod
Time frame: Day 0: the day of the implantation
The surgeon will have to say if the implantation of the device has been done or not
Time frame: 1 years after the implantation
1 year after the implantation of the device, radiographs will be realised to ensure that the implant is still well positioning
Time frame: 2 years after the implantation
2 years after the implantation of the device, radiographs will be realised to ensure that the implant is still weel positioning
Time frame: 3 years after the implantation
3 years after the implantation of the device, radiographs will be realised to ensure that the implant is still weel positioning
Time frame: 3 months, 6 months, 9 months, 1 year, 2 years and 3 years after the implantation
The elongation of the implant will be measured in mm on the digital radiography
Time frame: 3 months, after the implantation
Self-assessment of pain using a visual analog scale
Time frame: months after the implantation
Self-assessment of pain using a visual analog scale
Time frame: 9 months after the implantation
Self-assessment of pain using a visual analog scale
Time frame: 1 year after the implantation
Self-assessment of pain using a visual analog scale
Time frame: Day 0
Assess quality of life in the questionnaire PedsQL
Time frame: 6 months after the implantation
Assess quality of life in the questionnaire PedsQL
Time frame: 1 year after the implantation
Assess quality of life in the questionnaire PedsQL
Time frame: Day 0
Number of participant with ease for the surgeon to implant the device,
Time frame: Day 0
Number of participant with closure of the wound without tension,
Time frame: Day 0
Number participant with good positioning of the radiographic implant.
Time frame: 1 year
Measure of the number of medical visit in the year after implant
Time frame: 1 year
Number of iterative extensions of 1 year.
Time frame: 3 months, 6 months, 9 month and 1 year
Number of participant with correction of deformation immediately after the operation,
Time frame: 3 months after implantation
Number of participant with correction of deformation immediately after the operation,
Time frame: 6 months after implantation
Loss correction at 1 year
Time frame: 9 month after implantation
Loss correction at 1 year
Time frame: 1 year after implantation
Loss correction at 1 year
Time frame: 1 year
Increase the distance T1-S1 at 1 year (in mm)
Time frame: 3 months after implantation
Effective Elongation measured on radiographs of specification of the device (in mm)
Time frame: 6 months after implantation
Effective Elongation measured on radiographs of specification of the device (in mm)
Time frame: 9 month after implantation
Effective Elongation measured on radiographs of specification of the device (in mm)
Time frame: 1 year after implantation
Effective Elongation measured on radiographs of specification of the device (in mm)
Time frame: 1 years
describe the nature of complication
Time frame: 2 years
describe the nature of complication
Time frame: 3 years
describe the nature of complication
Time frame: 5 years
describe the nature of complication
University Hospital, Toulouse
Other
Acronym: ASTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06396286
Adolescent Idiopathic Scoliosis, Bone Diseases
Bologna, Italy
View Trial DetailsNCT02998138
Bone Diseases, Chronic Pain
Stanford, California, United States
View Trial DetailsNCT05107310
Bone Diseases, Kyphosis
Stockholm, Sweden
View Trial DetailsNCT07722117
Alternative to Reduce Analgesic Dependence, Ankylosis
Paris, France
View Trial Details